Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023--February 2024.

Bibliographic Details
Title: Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023--February 2024.
Authors: Patel, Mira C.1, Nguyen, Ha T.1, Pascua, Philippe Noriel Q.1, Gao, Rongyuan1, Steel, John1, Kondor, Rebecca J.1, Gubareva, Larisa V.1
Source: Emerging Infectious Diseases. Jul2024, Vol. 30 Issue 7, p1410-1415. 6p.
Subject Terms: *H7N9 Influenza, *INFLUENZA, *DENGUE hemorrhagic fever, *OSELTAMIVIR, *CEFTAZIDIME, *EMERGING infectious diseases, *NOCARDIOSIS, *FOODBORNE diseases
Abstract: The article focuses on antiviral resistance in influenza viruses, particularly targeting matrix protein 2 (M2), neuraminidase (NA), and cap-dependent endonuclease (CEN) through direct-acting antivirals. Topics include the emergence of resistance mutations like H275Y in NA inhibitors such as oseltamivir, the global surveillance efforts by WHO-GISRS to monitor resistance.
Database: Academic Search Complete
More Details
ISSN:10806040
DOI:10.3201/eid3007.240480
Published in:Emerging Infectious Diseases
Language:English